Shinome Brief

Friday 11 September 2026

Private edition · 12 min read

Two YouTube fitness feeds (Jeff Nippard, Renaissance Periodization) returned 404 for a second day; the fitness science below comes from PubMed, r/AdvancedFitness and the trade press.

AI & Tech

7 stories

The lead

OpenAI ships ChatGPT for Financial Services, built with Morgan Stanley and Evercore

That list is the junior banking and equity research job description, which is why CNBC ran it as a story about entry level work. It sits on ChatGPT Enterprise controls, with role based access, encryption and workspace logs that compliance teams can export into audit workflows.

Launched 10 September on GPT-6 Astra, it puts Daloopa, PitchBook, LSEG News and Crunchbase data inside ChatGPT Enterprise with no separate data contracts to negotiate. OpenAI says the design partnership with Morgan Stanley and Evercore pointed it at company research, financial data analysis and pitchbook creation.

OpenAI

JOBBring this into interviews before they do: say the data assembly half of an analyst job is now a product, and that what you sell is judgement, client handling and knowing when the model is wrong.

  1. 1

    OpenAI opens the Agents API, a managed service that runs agents in its own cloud

    Released the same day, the Agents API is a managed service powered by the Codex harness, built for orchestration, long running sessions and tool use. The agent runs on OpenAI infrastructure rather than on your machine.

    OpenAI

    JOBTest it against career-ops: if the daily job sweep can run as a scheduled cloud agent, your applications keep moving on days you never open the laptop.

  2. 2

    DeepSeek releases V4.1 Flash under MIT with a one million token context

    A multimodal mixture of experts model with a 552 billion parameter backbone, weights on Hugging Face, and off peak API pricing around 0.15 dollars per million input tokens against 0.60 out. A teardown of the safetensors puts the total at 748 billion, so the headline parameter count is still disputed.

    DeepSeek via r/LocalLLaMA

    SHINOMEFor Coach OS drafting, a one million token context at that price means a client's whole history fits in one call, so test it against the current model before paying frontier rates for template work.

  3. 3

    Cognition's SWE-2 lands within a point of Fable 5.1 on its own benchmark at a fraction of the cost

    SWE-2 scored 50.0 on Cognition's FrontierCode 1.1 Main against 50.9 for Fable 5.1, and the company claims up to 70 percent lower running cost. The numbers are self reported and the model is post trained on Kimi K3.

    Cognition

    CONVOUse it as the example when someone senior asks whether AI spend keeps climbing: the frontier is being matched on price now, and the benchmark is the vendor's own.

  4. 4

    Anthropic says Chinese labs used millions of Claude exchanges to train their own models

    Anthropic says it detected unauthorised use of Claude by China based labs including Alibaba and Moonshot AI to improve their systems. It follows Monday's NSA, FBI and CISA notice naming six Chinese AI firms over distillation.

    CNBC

    CONVOWorth a line in any conversation about vendor risk: the argument has moved from copyright to whether a supplier can prove where its model's behaviour came from.

  5. 5

    Universal Music and ElevenLabs will let users remix a licensed catalogue

    Universal announced a multiyear licensing deal with ElevenLabs for a platform where users build remixes, mashups and new versions from its catalogue. It arrives a day after Suno's first model trained with record industry help.

    The Verge

    CONVOThe rights holders stopped suing and started licensing in the same week, which is the cleanest example you have of an industry pricing AI instead of fighting it.

  6. 6

    Slack adds Surfaces, which generates dashboards and reports inside a chat

    Slackforce Surfaces lets a user describe a report, poll, dashboard or microsite to Slackbot, which assembles it from conversations and connected apps such as Google Drive and Salesforce.

    The Verge

    JOBIf an employer asks how you would cut reporting time on day one, this is the concrete answer: the reporting layer moves into the chat tool the team already lives in.

Finance & Markets

7 stories

The lead

The ECB raises its main rate to 2.5 percent as the energy shock pushes inflation to 3.3 percent

It raised its 2027 and 2028 inflation projections to 2.5 and 2.1 percent and nudged growth up to 0.9 and 1.4 percent, and Lagarde called the move a no brainer. The war around Hormuz is doing the work, so the path depends on crude, not on the labour market.

The second hike of 2026, a quarter point, after August euro area inflation came in at 3.3 percent, the highest since September 2023, with energy inflation at 14.3 percent. The ECB warned inflation should stay well above 2 percent for a prolonged period.

Le Temps

CONVOThis is the one macro fact to carry into every Vaud and Geneva interview this week: the ECB is tightening into an oil shock while the SNB sits far lower, and that gap sets the franc and Swiss corporate funding costs.

  1. 1

    UBS says Chinese competition is a longer lasting threat to Swiss industry than US tariffs

    A UBS study published Thursday treats the US tariffs as a cyclical shock to Swiss industry, while Chinese competition settles in and moves progressively into high value added sectors.

    Le Temps

    JOBUse it to pick targets: industrial firms facing structural Chinese competition are the ones restructuring, and restructuring is where interim finance mandates come from.

  2. 2

    The Federal Council backs the Lex On and overrules SMEs and industry groups

    Two motions in Bern tried to reverse the March change to the Swissness law, which allows the Swiss cross on goods made abroad under certain conditions. The Council supports the new practice and concedes only an evaluation of the Swissness provisions.

    Le Temps

    CONVOA short, safe Swiss opener for a networking call: the country just loosened what Swiss made means, and every consumer brand in Vaud has an opinion about it.

  3. 3

    Bessent says a large bank will be sanctioned on Monday under the Iran strategy

    The US Treasury Secretary said a large bank would be sanctioned next week as economic pressure on Iran is stepped up, without naming it.

    CNBC

    JOBSanctions designations pull compliance and KYC headcount forward: ping the Geneva and Lausanne agencies on Monday once the name is out, because remediation desks staff up fast.

  4. 4

    Chinese Nvidia rival Enflame closes 206 percent up on its Shanghai debut

    The AI chipmaker, one of China's four little dragons, soared on its first day of trading as domestic demand for AI silicon held up.

    CNBC

    CONVOPair it with the distillation story above when the conversation turns to China: the copying argument and a 206 percent chip listing are the same bet on domestic substitution.

  5. 5

    Swiss medtech reached 26 billion francs of revenue with growth slowing to 5.5 percent

    The Swiss medical device sector came out of two hard years in 2024 and 2025, with cost pressure and foreign competition slowing growth and flattening headcount. The industry expects a rebound from 2026.

    Le Temps

    JOBIt is the sector next door to your NewBiologix year: a flat headcount with a forecast rebound is exactly when firms hire on contract first, so it belongs in the interim target list.

  6. 6

    Richemont moves a generation closer as Anton Rupert becomes vice chairman

    Anton Rupert, 39, son of chairman and owner Johann Rupert, was appointed vice chairman of the Geneva luxury group, confirming him as the likely next leader.

    Le Temps

    CONVOKeep it for Geneva rooms: family succession at Richemont is the local version of the governance question every senior person likes being asked about.

Fitness & Performance

7 stories
Last 7 daysThe week's research moved from how much weight comes off to what comes off with it. A review argues that lean mass lost on incretin drugs is not the same as losing contractile muscle, a bone review says caloric restriction costs bone density and names the countermeasures, and a small trial found that turning blood flow restriction pressure up bought more muscle and more squat strength. The business news ran the other way, towards selling to people who are not members.
This quarterFor ninety days the quarter bucket has ranked add-ons and found small effects: whole body vibration and blood flow restriction on 29 June, creatine on 6 July, anti-obesity medications for maintenance on 9 July, photobiomodulation on 20 July, keto at matched energy on 13 August. Late August turned the briefs onto the instruments, with smartwatch calorie error on 2 September and doubly labelled water on 4 September, then the HMB ceiling on 7 September and the bariatric surgery ceiling on 8 September, then aerobic versus resistance work split by outcome on 10 September. Today does something the quarter has not done yet: instead of ranking a method, it disputes the measurement the whole muscle loss argument runs on, since the drug reviews in the quarter bucket judged lean mass by DXA and this review says DXA lean mass and working muscle are not the same number.

The lead

A review argues lean mass lost on incretin drugs is not the same as losing working muscle

This is a narrative review, not new measurement, so it moves the argument rather than settling it. Its point is that lean mass on a scan and contractile muscle are different quantities, and the outcome worth tracking is what the person can do.

In the September issue, two Korean endocrinology teams review body composition on GLP-1 and dual agonist therapy. They report preferential fat loss with relative preservation of lean mass, and state that the available evidence does not show obvious harm to muscle strength, physical performance, falls, fractures or quality of life, while noting long term data are limited, especially in people who start with little muscle reserve.

Diabetes & Metabolism Journal

sharpensmuscle-is-capitalTrain while cutting still holds, but the scare line that these drugs strip muscle is not what this review found in the functional data.

SHINOMEWhen a client raises the injections, drop the muscle wasting headline and use the review's framing instead: keep lifting, keep protein high, and track strength numbers and photos rather than the scale, because that is the measurement the evidence actually cares about.

  1. 1

    In 24 youth soccer players, more blood flow restriction pressure bought more muscle and more squat

    Six weeks of lower limb training at 30 percent of one rep max, three times a week, at 40 or 60 percent arterial occlusion pressure against a no restriction control. Lower limb muscle mass rose 0.55 kg at 40 percent and 0.83 kg at 60 percent, squat one rep max rose 6.50 kg and 9.25 kg, and jump and agility improved equally in both restriction groups with no change in the 30 metre sprint.

    Journal of Sports Science and Medicine

    sharpensmuscle-is-capitalThe dose of restriction changed the result, which is the first time this quarter's blood flow restriction papers found a gradient rather than a small flat effect.

    SHINOMELeave this out of client programmes: 24 trained teenagers under supervision is not a reason to add cuffs to online coaching, and the load that moved the numbers was still training.

  2. 2

    A review sets out why bone density falls during weight loss and what has been tested against it

    The review reports that weight loss raises bone turnover and reduces bone mineral density and bone quality, with greater loss in older and leaner adults and after severe restriction such as incretin drugs or bariatric surgery. It names adequate calcium and protein intake and exercise as the countermeasures with current evidence, and says randomised trials are still needed for the rest.

    Current Osteoporosis Reports

    sharpensenergy-balanceSame deficit, different bill: severity of restriction, not the diet's name, is what the review links to bone loss.

    SHINOMEOne more reason the deficit size is the programme decision, not a detail: if a client wants to go faster, this is the cost you can name without inventing a mechanism.

  3. 3

    A Strength and Conditioning Journal review finds the sleep and muscle link is mechanism and observation, not trials

    The review examines the mechanistic and observational evidence tying sleep to muscle hypertrophy and separates what is known from what is assumed. The trade coverage frames it as a warning about how confidently operators message sleep to members.

    Club Solutions

    sharpenssimple-systemSleep stays a habit worth defending for adherence, and the hypertrophy claim built on it is not evidenced at trial level.

    SHINOMERewrite any Shinome sleep copy that promises muscle: say sleep protects adherence and training quality, which is what you can defend, and stop there.

  4. 4

    Gold's Gym launches Hone, a training app aimed at people who are not members

    The app is the first move under new sole CEO Brad Reynolds and will eventually sell coaching to non members, putting a legacy gym brand into the same market as independent online coaches.

    Athletech News

    SHINOMERead the positioning before they scale it: your edge against a brand app is a named human who answers, so make the reply time and the check-in call the thing you actually sell.

  5. 5

    Two studio operators lay out the 90 day presale that funded their openings

    About one studio in a thousand opens fully funded. Two operators who managed it describe setting a target and signing founding members before the space is ready.

    Athletech News

    SHINOMEThe same shape works with no space at all: set a founding member number for the next Shinome cohort, give it a start date, and sell it before the programme is fully built.

  6. 6

    Planet Fitness rebrands as cheaper rivals take share in the category it invented

    The high volume low price giant is rolling out a refreshed look and an app redesign after struggling to hold its lead in the segment it created.

    Athletech News

    SHINOMEEvidence for the pricing argument you keep having: at the bottom of the market the only defence left is brand and app, so do not compete there.